Type Congenic; Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Additional information on Congenic nomenclature. Mating System +/+ sibling x Heterozygote (Female x Male) 16-DEC-08 Species laboratory mouse Generation N10F6 (03-DEC-12)
Generation DefinitionsDonating Investigator Cristina M Backman, National Institute on Drug Abuse (NIH) Description
Mice homozygous for this dopamine transporter IRES-cre (DATIREScre) mutant allele are viable and fertile. Cre recombinase activity is observed as early as embryonic day 15, and co-localizes with endogenous gene expression in adult dopaminergic cell groups (substantia nigra (SN) and ventral tegmental area (VTA), as well as in the retrorubral field). Lesser Cre recombinase activity occurs in adult olfactory bulb glomeruli, mimicking the known lower Slc6a3 (or DAT) expression in this tissue. Although the pattern and intensity of DAT immunostaining in the SN, VTA and striatum do not differ between wild-type and mutant mice, striatum DAT protein levels are moderately reduced (17%) in heterozygotes and significantly reduced (47%) in homozygotes. This diminution in homozygous striatum is associated with significantly increased neuropeptide PDyn (but not D1, D2, or PPE) mRNA levels compared to wild-type, while such an increase is not observed in heterozygotes. When bred with mice containing a loxP-flanked sequence of interest, Cre-mediated recombination will result in deletion of the flanked genome in dopaminergic neurons. As such, these mutant mice may be useful in neurobiological studies to facilitate the analysis of gene function in dopaminergic neurons, such as drug addiction or Parkinson's disease.In an attempt to offer alleles on well-characterized or multiple genetic backgrounds, alleles are frequently moved to a genetic background different from that on which an allele was first characterized. It should be noted that the phenotype could vary from that originally described. The strain description will be modified as published results become available.
Development
To co-express both genes from the endogenous promoter (and minimize interference with endogenous gene function), a targeting vector was designed to insert an internal ribosome entry site-linked Cre recombinase gene (IRES-Cre) and FRT-flanked PGK-neo cassette 23 bp downstream from the stop codon of the endogenous gene. The construct was electroporated into C57BL/6-derived CMT2 embryonic stem (ES) cells. Correctly targeted ES cells were injected into blastocysts and chimeric mice were bred to C57BL/6 mice. The FRT-flanked neo cassette was removed in the germline mice by intercrossing with a Flpe-deleter strain on a mixed B6;SJL background (see Stock No. 003800). The resulting mutant offspring (now harboring this DATIREScre allele) were maintained on this mixed genetic background prior to arrival at The Jackson Laboratory. Upon arrival, mice were backcrossed to the C57BL/6J inbred strain for at least five generations.
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
Parkinson's Disease Models
005987 129-Achetm1Loc/J 007587 129S-Park2tm1Rpa/J 002779 129S-Parp1tm1Zqw/J 017001 129S.B6N-Plk2tm1Elan/J 016198 129S6.Cg-Tg(Camk2a-tTA)1Mmay/JlwsJ 004608 B6(Cg)-Htra2mnd2/J 008133 B6.129-Sncbtm1Sud/J 008084 B6.129P2-Drd4tm1Dkg/J 004744 B6.129P2-Esr1tm1Ksk/J 013586 B6.129P2-Gt(ROSA)26Sortm1Nik/J 002609 B6.129P2-Nos2tm1Lau/J 008843 B6.129P2-Sncgtm1Vlb/J 016566 B6.129S-Hcn1tm2Kndl/J 004322 B6.129S1-Mapk10tm1Flv/J 003190 B6.129S2-Drd2tm1Low/J 006582 B6.129S4-Park2tm1Shn/J 017946 B6.129S4-Pink1tm1Shn/J 005934 B6.129S4-Ucp2tm1Lowl/J 004936 B6.129S6(Cg)-Spp1tm1Blh/J 012453 B6.129X1(FVB)-Lrrk2tm1.1Cai/J 017009 B6.129X1-Nfe2l2tm1Ywk/J 009346 B6.Cg-Lrrk2tm1.1Shn/J 005491 B6.Cg-Mapttm1(EGFP)Klt Tg(MAPT)8cPdav/J 006577 B6.Cg-Park7tm1Shn/J 000567 B6.Cg-T2J +/+ Qkqk-v/J 007004 B6.Cg-Tg(Camk2a-tTA)1Mmay/DboJ 003139 B6.Cg-Tg(DBHn-lacZ)8Rpk/J 007673 B6.Cg-Tg(Gad1-EGFP)3Gfng/J 012466 B6.Cg-Tg(Lrrk2)6Yue/J 012467 B6.Cg-Tg(Lrrk2*G2019S)2Yue/J 008323 B6.Cg-Tg(Mc4r-MAPT/Sapphire)21Rck/J 008321 B6.Cg-Tg(Npy-MAPT/Sapphire)1Rck/J 008324 B6.Cg-Tg(Pmch-MAPT/CFP)1Rck/J 008322 B6.Cg-Tg(Pomc-MAPT/Topaz)1Rck/J 007894 B6.Cg-Tg(Rgs4-EGFP)4Lvt/J 012588 B6.Cg-Tg(TH-ALPP)1Erav/J 012265 B6.Cg-Tg(THY1-SNCA*A30P)TS2Sud/J 008859 B6.Cg-Tg(THY1-SNCA*A53T)F53Sud/J 008135 B6.Cg-Tg(THY1-SNCA*A53T)M53Sud/J 008601 B6.Cg-Tg(Th-cre)1Tmd/J 013583 B6.Cg-Tg(tetO-LRRK2)C7874Cai/J 000544 B6.D2-Cacna1atg/J 012445 B6.FVB-Tg(LRRK2)WT1Mjfa/J 012446 B6.FVB-Tg(LRRK2*G2019S)1Mjfa/J 008364 B6;129-Chattm1(cre/ERT)Nat/J 009688 B6;129-Dbhtm2(Th)Rpa Thtm1Rpa/J 008883 B6;129-Gt(ROSA)26Sortm1(SNCA*A53T)Djmo/TmdJ 008889 B6;129-Gt(ROSA)26Sortm2(SNCA*119)Djmo/TmdJ 008886 B6;129-Gt(ROSA)26Sortm3(SNCA*E46K)Djmo/TmdJ 009347 B6;129-Lrrk2tm1.1Shn/J 016209 B6;129-Lrrk2tm2.1Shn/J 016210 B6;129-Lrrk2tm3.1Shn/J 013050 B6;129-Pink1tm1Aub/J 004807 B6;129-Psen1tm1Mpm Tg(APPSwe,tauP301L)1Lfa/Mmjax 006390 B6;129-Sncatm1Sud Sncbtm1.1Sud/J 008532 B6;129-Thtm1(cre/Esr1)Nat/J 008333 B6;129P2-Dldtm1Ptl/J 008333 B6;129P2-Dldtm1Ptl/J 002596 B6;129P2-Nos2tm1Lau/J 003243 B6;129S-Tnfrsf1atm1Imx Tnfrsf1btm1Imx/J 003692 B6;129X1-Sncatm1Rosl/J 016575 B6;C3-Tg(PDGFB-LRRK2*G2019S)340Djmo/J 016576 B6;C3-Tg(PDGFB-LRRK2*R1441C)574Djmo/J 008169 B6;C3-Tg(Prnp-MAPT*P301S)PS19Vle/J 004479 B6;C3-Tg(Prnp-SNCA*A53T)83Vle/J 000231 B6;C3Fe a/a-Csf1op/J 012450 B6;D2-Tg(tetO-SNCA)1Cai/J 013725 B6;SJL-Tg(LRRK2)66Mjff/J 016555 B6;SJL-Tg(Nqo1-ALPP)1Jaj/J 008473 B6;SJL-Tg(THY1-SNCA*A30P)M30Sud/J 008134 B6;SJL-Tg(THY1-SNCA*A30P)TS2Sud/J 016976 B6C3-Tg(tetO-SNCA*A53T)33Vle/J 000506 B6C3Fe a/a-Qkqk-v/J 003741 B6D2-Tg(Prnp-MAPT)43Vle/J 018768 B6N.Cg-Tg(SNCA*E46K)3Elan/J 012621 C.129S(B6)-Chrna3tm1.1Hwrt/J 016120 C57BL/6-Lrrk1tm1.1Mjff/J 012444 C57BL/6-Lrrk2tm1Mjfa/J 008389 C57BL/6-Tg(THY1-SNCA)1Sud/J 012769 C57BL/6-Tg(Thy1-Sncg)HvP36Putt/J 005706 C57BL/6-Tg(tetO-CDK5R1/GFP)337Lht/J 006618 C57BL/6-Tg(tetO-COX8A/EYFP)1Ksn/J 008245 C57BL/6J-Tg(Th-SNCA)5Eric/J 008239 C57BL/6J-Tg(Th-SNCA*A30P*A53T)39Eric/J 016122 C57BL/6N-Lrrk1tm1.1Mjff Lrrk2tm1.1Mjff/J 016121 C57BL/6N-Lrrk2tm1.1Mjff/J 016123 C57BL/6N-Sncatm1Mjff/J 016936 C57BL/6N-Tg(Thy1-SNCA)12Mjff/J 017682 C57BL/6N-Tg(Thy1-SNCA)15Mjff/J 007677 CB6-Tg(Gad1-EGFP)G42Zjh/J 009610 FVB/N-Tg(LRRK2)1Cjli/J 009609 FVB/N-Tg(LRRK2*G2019S)1Cjli/J 009604 FVB/N-Tg(LRRK2*R1441G)135Cjli/J 009090 FVB/NJ-Tg(Slc6a3-PARK2*Q311X)AXwy/J 017678 FVB;129-Pink1tm1Aub Tg(Prnp-SNCA*A53T)AAub/J 017744 FVB;129-Tg(Prnp-SNCA*A53T)AAub/J 010710 FVB;129S6-Sncatm1Nbm Tg(SNCA)1Nbm/J 010788 FVB;129S6-Sncatm1Nbm Tg(SNCA*A30P)1Nbm Tg(SNCA*A30P)2Nbm/J 010799 FVB;129S6-Sncatm1Nbm Tg(SNCA*A53T)1Nbm Tg(SNCA*A53T)2Nbm/J 004808 STOCK Mapttm1(EGFP)Klt Tg(MAPT)8cPdav/J 000942 STOCK Pitx3ak/2J 014092 STOCK Tg(ACTB-tTA2,-MAPT/lacZ)1Luo/J 006340 STOCK Tg(Gad1-EGFP)98Agmo/J 017000 STOCK Tg(SNCA*E46K)3Elan/J 008474 STOCK Tg(THY1-SNCA*A53T)F53Sud/J 008132 STOCK Tg(THY1-Snca)M1mSud/J 012441 STOCK Tg(tetO-LRRK2*G2019S)E3Cai/J 012442 STOCK Tg(tetO-SNCA*A53T)E2Cai/J 012449 STOCK Tg(teto-LRRK2)C7874Cai/J View Parkinson's Disease Models (109 strains)
Strains carrying other alleles of Slc6a3
016583 C57BL/6N-Tg(Slc6a3-icre/ERT2)2Gloss/J 009090 FVB/NJ-Tg(Slc6a3-PARK2*Q311X)AXwy/J View Strains carrying other alleles of Slc6a3 (2 strains)
Strains carrying other alleles of cre
004337 129(Cg)-Foxg1tm1(cre)Skm/J 008569 129-Alpltm1(cre)Nagy/J 017611 129-Mcm2tm1(cre/ERT2)Scpr/J 005989 129;FVB-Tg(PTH-cre)4167Slib/J 007179 129S.Cg-Tg(UBC-cre/ERT2)1Ejb/J 007915 129S.FVB-Tg(Amh-cre)8815Reb/J 003328 129S/Sv-Tg(Prm-cre)58Og/J 004302 129S1/Sv-Hprttm1(cre)Mnn/J 003960 129S6-Tg(Prnp-GFP/cre)1Blw/J 008523 129S6.Cg-Tg(NPHS2-cre)295Lbh/BroJ 009575 B6(129S4)-Et(cre/ERT2)119Rdav/J 009580 B6(129S4)-Et(cre/ERT2)1382Rdav/J 012688 B6(129S4)-Et(cre/ERT2)13866Rdav/J 009581 B6(129S4)-Et(cre/ERT2)1642Rdav/J 009582 B6(129S4)-Et(cre/ERT2)1645Rdav/J 009583 B6(129S4)-Et(cre/ERT2)1957Rdav/J 009584 B6(129S4)-Et(cre/ERT2)2007Rdav/J 009585 B6(129S4)-Et(cre/ERT2)2047Rdav/J 009574 B6(129S4)-Et(cre/ERT2)21Rdav/J 009577 B6(129S4)-Et(cre/ERT2)296Rdav/J 009578 B6(129S4)-Et(cre/ERT2)398Rdav/J 009573 B6(129S4)-Et(cre/ERT2)4Rdav/J 010688 B6(129S4)-Et(cre/ERT2)6691Rdav/J 010689 B6(129S4)-Et(cre/ERT2)6959Rdav/J 010690 B6(129S4)-Et(cre/ERT2)7089Rdav/J 010691 B6(129S4)-Et(cre/ERT2)7149Rdav/J 010692 B6(129S4)-Et(cre/ERT2)7381Rdav/J 010693 B6(129S4)-Et(cre/ERT2)8120Rdav/J 010694 B6(129S4)-Et(cre/ERT2)8131Rdav/J 009579 B6(129S4)-Et(cre/ERT2)837Rdav/J 010695 B6(129S4)-Et(cre/ERT2)9699Rdav/J 009587 B6(129S4)-Et(icre)1402Rdav/J 009588 B6(129S4)-Et(icre)1470Rdav/J 009589 B6(129S4)-Et(icre)1555Rdav/J 009586 B6(129S4)-Et(icre)754Rdav/J 010696 B6(129S4)-Et(icre/ERT2)10596Rdav/J 010697 B6(129S4)-Et(icre/ERT2)10727Rdav/J 012689 B6(129S4)-Et(icre/ERT2)14163Rdav/J 012690 B6(129S4)-Et(icre/ERT2)14208Rdav/J 012694 B6(129S4)-Et(icre/ERT2)14915Rdav/J 012687 B6(129S4)-Tg(SYN1-icre/mRFP1)9934Rdav/J 010774 B6(Cg)-Calb2tm1(cre)Zjh/J 013730 B6(Cg)-Calb2tm2.1(cre/ERT2)Zjh/J 017562 B6(Cg)-Cd8atm1.1(cre)Koni/J 012704 B6(Cg)-Crhtm1(cre)Zjh/J 010705 B6(Cg)-Dlx5tm1(cre/ERT2)Zjh/J 013048 B6(Cg)-Etv1tm1.1(cre/ERT2)Zjh/J 018448 B6(Cg)-Foxn1tm3(cre)Nrm/J 010776 B6(Cg)-Lhx6tm1(cre/ERT2)Zjh/J 010777 B6(Cg)-Pvalbtm1(cre/ERT2)Zjh/J 010708 B6(Cg)-Ssttm1(cre/ERT2)Zjh/J 016223 B6(Cg)-Tg(Phox2b-cre)3Jke/J 016829 B6(SJL)-Pou5f1tm1.1(cre/Esr1*)Yseg/J 018867 B6.129(Cg)-Axin2tm1(cre/ERT2)Rnu/J 016959 B6.129(Cg)-Foxp3tm4(YFP/cre)Ayr/J 008463 B6.129-Gt(ROSA)26Sortm1(cre/ERT2)Tyj/J 008320 B6.129-Leprtm2(cre)Rck/J 017526 B6.129-Nos1tm1(cre)Mgmj/J 005697 B6.129-Otx1tm4(cre)Asim/J 018938 B6.129-Tac2tm1.1(cre)Qima/J 017769 B6.129-Trpv1tm1(cre)Bbm/J 004146 B6.129-Tg(Pcp2-cre)2Mpin/J 008710 B6.129P2(129S4)-Hprttm10(Ple162-EGFP/cre)Ems/Mmjax 008877 B6.129P2(129S4)-Hprttm12(Ple177-EGFP/cre)Ems/Mmjax 009116 B6.129P2(129S4)-Hprttm16(Ple167-EGFP/cre)Ems/Mmjax 008709 B6.129P2(129S4)-Hprttm9(Ple178-EGFP/cre)Ems/Mmjax 006785 B6.129P2(C)-Cd19tm1(cre)Cgn/J 021160 B6.129P2(Cg)-Cx3cr1tm2.1(cre/ERT)Litt/WganJ 006084 B6.129P2(Cg)-Foxg1tm1(cre)Skm/J 010611 B6.129P2(Cg)-Ighg1tm1(IRES-cre)Cgn/J 008875 B6.129P2-Lgr5tm1(cre/ERT2)Cle/J 016934 B6.129P2-Lgr6tm2.1(cre/ERT2)Cle/J 004781 B6.129P2-Lyz2tm1(cre)Ifo/J 016222 B6.129S(Cg)-Id2tm1.1(cre/ERT2)Blh/ZhuJ 013594 B6.129S-Atoh1tm5.1(Cre/PGR)Hzo/J 006600 B6.129S1-Mnx1tm4(cre)Tmj/J 005628 B6.129S2-Emx1tm1(cre)Krj/J 017578 B6.129S4-Mcpt8tm1(cre)Lky/J 003755 B6.129S4-Meox2tm1(cre)Sor/J 007893 B6.129S4-Myf5tm3(cre)Sor/J 019378 B6.129S6(Cg)-Ptf1atm2(cre/ESR1)Cvw/J 005623 B6.129S6-Shhtm2(cre/ERT2)Cjt/J 006878 B6.129S6-Taglntm2(cre)Yec/J 012839 B6.129X1(Cg)-Tnfrsf4tm2(cre)Nik/J 008712 B6.129X1-Twist2tm1.1(cre)Dor/J 006054 B6.C-Tg(CMV-cre)1Cgn/J 009642 B6.Cg(129)-Tg(Gh1-cre)1Sac/J 013590 B6.Cg-Braftm1Mmcm Ptentm1Hwu Tg(Tyr-cre/ERT2)13Bos/BosJ 006230 B6.Cg-Cebpatm1Dgt Tg(Mx1-cre)1Cgn/J 012360 B6.Cg-Erbb4tm1.1(cre/ERT2)Aibs/J 017763 B6.Cg-Pax7tm1(cre/ERT2)Gaka/J 012358 B6.Cg-Pvalbtm1.1(cre)Aibs/J 005622 B6.Cg-Shhtm1(EGFP/cre)Cjt/J 017346 B6.Cg-Tg(A930038C07Rik-cre)1Aibs/J 006149 B6.Cg-Tg(ACTA1-cre)79Jme/J 003574 B6.Cg-Tg(Alb-cre)21Mgn/J 006881 B6.Cg-Tg(Aqp2-cre)1Dek/J 011104 B6.Cg-Tg(Atoh1-cre)1Bfri/J 004682 B6.Cg-Tg(CAG-cre/Esr1*)5Amc/J 008520 B6.Cg-Tg(CD2-cre)4Kio/J 009350 B6.Cg-Tg(CDX2-cre)101Erf/J 009352 B6.Cg-Tg(CDX2-cre*)189Erf/J 005359 B6.Cg-Tg(Camk2a-cre)T29-1Stl/J 012237 B6.Cg-Tg(Cdh16-cre)91Igr/J 006137 B6.Cg-Tg(Cdh5-cre)7Mlia/J 016241 B6.Cg-Tg(Col1a1-cre/ERT2)1Crm/J 016237 B6.Cg-Tg(Col1a2-cre/ERT)7Cpd/J 006368 B6.Cg-Tg(Cr2-cre)3Cgn/J 008538 B6.Cg-Tg(Cspg4-cre/Esr1*)BAkik/J 006663 B6.Cg-Tg(Eno2-cre)39Jme/J 005069 B6.Cg-Tg(Fabp4-cre)1Rev/J 012712 B6.Cg-Tg(Fev-cre)1Esd/J 012849 B6.Cg-Tg(GFAP-cre/ERT2)505Fmv/J 012886 B6.Cg-Tg(Gfap-cre)73.12Mvs/J 012887 B6.Cg-Tg(Gfap-cre)77.6Mvs/J 003573 B6.Cg-Tg(Ins2-cre)25Mgn/J 008068 B6.Cg-Tg(Itgax-cre)1-1Reiz/J 008781 B6.Cg-Tg(Kap-cre)29066/2Sig/J 012837 B6.Cg-Tg(Lck-cre)3779Nik/J 003802 B6.Cg-Tg(Lck-cre)548Jxm/J 006889 B6.Cg-Tg(Lck-cre)I540Jxm/J 009643 B6.Cg-Tg(Lhb-cre)1Sac/J 003556 B6.Cg-Tg(Mx1-cre)1Cgn/J 007742 B6.Cg-Tg(Myh11-cre,-EGFP)2Mik/J 008205 B6.Cg-Tg(NPHS2-cre)295Lbh/J 003771 B6.Cg-Tg(Nes-cre)1Kln/J 010536 B6.Cg-Tg(Pcp2-cre)3555Jdhu/J 005975 B6.Cg-Tg(Plp1-cre/ERT)3Pop/J 008827 B6.Cg-Tg(Prdm1-cre)1Masu/J 005584 B6.Cg-Tg(Prrx1-cre)1Cjt/J 003967 B6.Cg-Tg(Rbp3-cre)528Jxm/J 021614 B6.Cg-Tg(S100A8-cre,-EGFP)1Ilw/J 008454 B6.Cg-Tg(Sox2-cre)1Amc/J 006361 B6.Cg-Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/J 003966 B6.Cg-Tg(Syn1-cre)671Jxm/J 017491 B6.Cg-Tg(Tagln-cre)1Her/J 004128 B6.Cg-Tg(Tek-cre)12Flv/J 008863 B6.Cg-Tg(Tek-cre)1Ywa/J 008601 B6.Cg-Tg(Th-cre)1Tmd/J 007606 B6.Cg-Tg(Thy1-cre/ERT2,-EYFP)AGfng/J 012328 B6.Cg-Tg(Tyr-cre/ERT2)13Bos/J 008085 B6.Cg-Tg(UBC-cre/ERT2)1Ejb/J 008610 B6.Cg-Tg(Vav1-cre)A2Kio/J 008735 B6.Cg-Tg(Wap-cre)11738Mam/JKnwJ 009614 B6.Cg-Tg(Wfs1-cre/ERT2)2Aibs/J 009107 B6.Cg-Tg(Wnt1-cre)11Rth Tg(Wnt1-GAL4)11Rth/J 006234 B6.Cg-Tg(tetO-cre)1Jaw/J 016832 B6.FVB(129)-Tg(Alb1-cre)1Dlr/J 005657 B6.FVB(129)-Tg(Myh6-cre/Esr1*)1Jmk/J 006475 B6.FVB(129S4)-Tg(Ckmm-cre)5Khn/J 018422 B6.FVB(129X1)-Tg(Aicda-cre)1Rcas/J 006451 B6.FVB(129X1)-Tg(Sim1-cre)1Lowl/J 006333 B6.FVB(Cg)-Tg(Neurog3-cre)C1Able/J 014643 B6.FVB-Tg(CMA1-cre)6Thhe/J 011087 B6.FVB-Tg(Crh-cre)1Kres/J 003724 B6.FVB-Tg(EIIa-cre)C5379Lmgd/J 011069 B6.FVB-Tg(Gh1-cre)bKnmn/J 014647 B6.FVB-Tg(Ipfl-cre)6Tuv/J 011038 B6.FVB-Tg(Myh6-cre)2182Mds/J 010714 B6.FVB-Tg(Pomc-cre)1Stl/J 017535 B6.FVB-Tg(Slc32a1-cre)2.1Hzo/FrkJ 017490 B6.FVB-Tg(Stra8-cre)1Reb/LguJ 003394 B6.FVB-Tg(Zp3-cre)3Mrt/J 014579 B6.NOD-Tg(Foxp3-EGFP/cre)1aJbs/J 004586 B6.SJL-Tg(Vil-cre)997Gum/J 003552 B6129-Tg(Wap-cre)11738Mam/J 010531 B6;129-Bmi1tm1(cre/ERT)Mrc/J 008364 B6;129-Chattm1(cre/ERT)Nat/J 004847 B6;129-Gt(ROSA)26Sortm1(cre/ERT)Nat/J 010557 B6;129-Gt(ROSA)26Sortm3(rtTA,tetO-cre/ERT)Nat/J 010529 B6;129-Myf5tm1(cre)Mrc/J 010528 B6;129-Myf6tm2(cre)Mrc/J 008363 B6;129-Nefltm1(cre/ERT)Nat/J 017525 B6;129-Ntstm1(cre)Mgmj/J 005549 B6;129-Pax3tm1(cre)Joe/J 012476 B6;129-Pax7tm2.1(cre/ERT2)Fan/J 009600 B6;129-Six2tm3(EGFP/cre/ERT2)Amc/J 008532 B6;129-Thtm1(cre/Esr1)Nat/J 008531 B6;129-Vamp2tm1(cre/ERT)Nat/J 017968 B6;129-Tg(Cdh5-cre)1Spe/J 010988 B6;129P-Cyp11a1tm1(GFP/cre)Pzg/J 010985 B6;129P-Klf3tm1(cre/ERT2)Pzg/J 008529 B6;129P-Tg(Neurog1-cre/ERT2)1Good/J 007770 B6;129P2-Aicdatm1(cre)Mnz/J 015854 B6;129P2-Foxl2tm1(GFP/cre/ERT2)Pzg/J 012601 B6;129P2-Lyve1tm1.1(EGFP/cre)Cys/J 006668 B6;129P2-Omptm4(cre)Mom/MomJ 008069 B6;129P2-Pvalbtm1(cre)Arbr/J 012373 B6;129S-Hoxb1tm1(cre)Og/J 014541 B6;129S-Nos1tm1.1(cre/ERT2)Zjh/J 010987 B6;129S-Sox18tm1(GFP/cre/ERT2)Pzg/J 017593 B6;129S-Sox2tm1(cre/ERT2)Hoch/J 017685 B6;129S-Wisp3tm1(cre)Mawa/J 007001 B6;129S-Tg(UBC-cre/ERT2)1Ejb/J 009388 B6;129S1-Osr2tm2(cre)Jian/J 014551 B6;129S4-Dlx1tm1(cre/ERT2)Zjh/J 012463 B6;129S4-Foxd1tm1(GFP/cre)Amc/J 012464 B6;129S4-Foxd1tm2(GFP/cre/ERT2)Amc/J 011105 B6;129S4-Olig1tm1(cre)Rth/J 009576 B6;129S4-Et(cre/ERT2)278Rdav/J 006410 B6;129S6-Chattm2(cre)Lowl/J 012362 B6;129S6-Tg(Camk2a-cre/ERT2)1Aibs/J 017495 B6;129S7-Crim1tm1(GFP/cre/ERT2)Pzg/J 014638 B6;129X1-Cldn6tm1(cre/ERT2)Dam/J 009616 B6;C3-Tg(A930038C07Rik-cre)4Aibs/J 012433 B6;C3-Tg(ACTA1-rtTA,tetO-cre)102Monk/J 008844 B6;C3-Tg(Ctgf-cre)2Aibs/J 008839 B6;C3-Tg(Cyp39a1-cre)1Aibs/J 009117 B6;C3-Tg(Cyp39a1-cre)7Aibs/J 008848 B6;C3-Tg(Mybpc1-cre)2Aibs/J 009111 B6;C3-Tg(Scnn1a-cre)1Aibs/J 009112 B6;C3-Tg(Scnn1a-cre)2Aibs/J 009613 B6;C3-Tg(Scnn1a-cre)3Aibs/J 009103 B6;C3-Tg(Wfs1-cre/ERT2)3Aibs/J 017494 B6;D-Tg(Tshz3-GFP/cre)43Amc/J 003466 B6;D2-Tg(Sycp1-cre)4Min/J 014160 B6;DBA-Tg(S100b-EGFP/cre/ERT2)22Amc/J 014159 B6;DBA-Tg(Tmem100-EGFP/cre/ERT2)30Amc/J 015855 B6;DBA-Tg(Upk3a-GFP/cre/ERT2)26Amc/J 010803 B6;FVB-Tg(Adipoq-cre)1Evdr/J 008533 B6;FVB-Tg(Cspg4-cre)1Akik/J 003734 B6;FVB-Tg(GZMB-cre)1Jcb/J 004426 B6;SJL-Tg(Cga-cre)3Sac/J 003554 B6;SJL-Tg(Col2a1-cre)1Bhr/J 017738 B6;SJL-Tg(Foxl1-cre)1Khk/J 005249 B6;SJL-Tg(Krt1-15-cre/PGR)22Cot/J 007610 B6;SJL-Tg(Thy1-cre/ERT2,-EYFP)VGfng/J 007252 B6Ei.129S4-Tg(Prm-cre)58Og/EiJ 016225 B6N.129S6(Cg)-Scgb1a1tm1(cre/ERT)Blh/J 017310 B6N.Cg-Tg(Hsd17b1-icre/ERT2)3Casa/J 014094 B6N.Cg-Tg(Sox2-cre)1Amc/J 019509 B6N.FVB-Tg(BGLAP-cre)1Clem/J 017927 B6N.FVB-Tg(Mpz-cre)26Mes/J 010550 B6N.FVB-Tg(Penk-glc-2-cre/ERT2)2And/J 017743 B6N;129S-Prom1tm1(cre/ERT2)Gilb/J 003465 BALB/c-Tg(CMV-cre)1Cgn/J 012641 BALB/c-Tg(S100a4-cre)1Egn/YunkJ 010612 C.129P2(Cg)-Ighg1tm1(IRES-cre)Cgn/J 017353 C.129S4(B6)-Il13tm1(YFP/cre)Lky/J 017582 C.129S4(B6)-Mcpt8tm1(cre)Lky/J 004126 C.Cg-Cd19tm1(cre)Cgn Ighb/J 005673 C.Cg-Tg(Mx1-cre)1Cgn/J 006244 C.Cg-Tg(tetO-cre)1Jaw/J 009155 C57BL/6-Cldn6tm1(cre)Dkwu/J 017557 C57BL/6-Tg(BEST1-cre)1Jdun/J 016097 C57BL/6-Tg(Car1-cre)5Flt/J 011086 C57BL/6-Tg(Cck-cre)CKres/J 008766 C57BL/6-Tg(Cd8a-cre)1Itan/J 006474 C57BL/6-Tg(Grik4-cre)G32-4Stl/J 008314 C57BL/6-Tg(HBB-cre)12Kpe/J 008870 C57BL/6-Tg(Hspa2-cre)1Eddy/J 016261 C57BL/6-Tg(Nes-cre/ERT2)KEisc/J 012906 C57BL/6-Tg(Nes-cre/Esr1*)1Kuan/J 016617 C57BL/6-Tg(Nr4a1-EGFP/cre)820Khog/J 020287 C57BL/6-Tg(Pbsn-cre/Esr1*)14Abch/J 013148 C57BL/6-Tg(Pdgfra-cre)1Clc/J 008535 C57BL/6-Tg(Pf4-cre)Q3Rsko/J 006888 C57BL/6-Tg(Zp3-cre)1Gwh/J 003651 C57BL/6-Tg(Zp3-cre)93Knw/J 007567 C57BL/6J-Tg(Itgax-cre,-EGFP)4097Ach/J 021582 C57BL/6J-Tg(Mchr1-cre)1Emf/J 008661 C57BL/6J-Tg(Nkx2-1-cre)2Sand/J 003650 C57BL/6J-Tg(Zp3-cre)82Knw/KnwJ 018151 C57BL/6N-Krt17tm1(cre,Cerulean)Murr/GrsrJ 012686 C57BL/6N-Tg(Ppp1r2-cre)4127Nkza/J 016582 C57BL/6N-Tg(Slc32a1-icre/ERT2)3Gloss/J 016583 C57BL/6N-Tg(Slc6a3-icre/ERT2)2Gloss/J 016833 FVB(Cg)-Tg(Alb1-cre)1Dlr/J 012929 FVB(Cg)-Tg(Dhh-cre)1Mejr/J 011034 FVB(Cg)-Tg(Ghrhr-cre)3242Lsk/J 006405 FVB-Tg(Ckmm-cre)5Khn/J 006774 FVB-Tg(Col2a1-cre/ERT)KA3Smac/J 021024 FVB-Tg(Csf1r-icre)1Jwp/J 006954 FVB-Tg(Ddx4-cre)1Dcas/J 004600 FVB-Tg(GFAP-cre)25Mes/J 011037 FVB-Tg(Myh6-cre)2182Mds/J 006364 FVB-Tg(Nr5a1-cre)2Lowl/J 008537 FVB-Tg(Tek-cre)2352Rwng/J 014140 FVB.Cg-Myod1tm2.1(icre)Glh/J 006139 FVB.Cg-Tg(ACTA1-cre)79Jme/J 017595 FVB.Cg-Tg(CAG-cre/Esr1*)5Amc/J 006297 FVB.Cg-Tg(Eno2-cre)39Jme/J 018394 FVB.Cg-Tg(KRT5-cre/ERT2)2Ipc/JeldJ 008244 FVB.Cg-Tg(tetO-cre)1Jaw/J 003376 FVB/N-Tg(ACTB-cre)2Mrt/J 003314 FVB/N-Tg(EIIa-cre)C5379Lmgd/J 017928 FVB/N-Tg(Mpz-cre)26Mes/J 006143 FVB/N-Tg(Thy1-cre)1Vln/J 003377 FVB/N-Tg(Zp3-cre)3Mrt/J 019096 NOD.129P2(B6)-Lyz2tm1(cre)Ifo/NadlJ 013233 NOD.B6-Tg(Itgax-cre,-EGFP)4097Ach/J 013234 NOD.Cg-Tg(Cd4-cre)1Cwi/2AchJ 005732 NOD.Cg-Tg(Lck-cre)548Jxm/AchJ 013251 NOD.FVB-Tg(EIIa-cre)C5379Lmgd/J 008694 NOD/ShiLt-Tg(Foxp3-EGFP/cre)1cJbs/J 004986 NOD/ShiLt-Tg(Ins2-cre)3Lt/LtJ 003855 NOD/ShiLt-Tg(Ins2-cre)5Lt/LtJ 004987 NOD/ShiLt-Tg(Ins2-cre)6Lt/LtJ 012899 STOCK Agrptm1(cre)Lowl/J 012882 STOCK Ascl1tm1.1(Cre/ERT2)Jejo/J 012706 STOCK Ccktm1.1(cre)Zjh/J 012710 STOCK Ccktm2.1(cre/ERT2)Zjh/J 010910 STOCK Corttm1(cre)Zjh/J 007916 STOCK En1tm2(cre)Wrst/J 007917 STOCK En1tm7(cre/ESR1)Alj/J 007924 STOCK En2tm4(cre/ERT2)Alj/J 008464 STOCK Foxa2tm2.1(cre/Esr1*)Moon/J 016961 STOCK Foxp3tm9(EGFP/cre/ERT2)Ayr/J 010702 STOCK Gad2tm1(cre/ERT2)Zjh/J 010802 STOCK Gad2tm2(cre)Zjh/J 007913 STOCK Gli1tm3(cre/ERT2)Alj/J 018903 STOCK Gt(ROSA)26Sortm2(EGFP/cre)Alj/J 017606 STOCK Hopxtm2.1(cre/ERT2)Joe/J 008876 STOCK Hprttm11(Ple176-EGFP/cre)Ems/Mmjax 016879 STOCK Il17atm1.1(icre)Stck/J 018976 STOCK Kdrtm1(cre)Sato/J 017701 STOCK Kiss1tm1.1(cre/EGFP)Stei/J 007022 STOCK Mnx1tm4(cre)Tmj Smn1tm1Msd Tg(SMN2*delta7)4299Ahmb Tg(SMN2)89Ahmb/J 004192 STOCK Mttptm2Sgy Ldlrtm1Her Apobtm2Sgy Tg(Mx1-cre)1Cgn/J 014180 STOCK Myocdtm1(cre)Jomm/J 014552 STOCK Nkx2-1tm1.1(cre/ERT2)Zjh/J 017536 STOCK Nkx6-2tm1(cre/ERT2)Fsh/J 006953 STOCK Notch1tm3(cre)Rko/J 006677 STOCK Olfr151tm28(cre)Mom/MomJ 011103 STOCK Olig2tm2(TVA,cre)Rth/J 009061 STOCK Osr1tm1(EGFP/cre/ERT2)Amc/J 010530 STOCK Pax7tm1(cre)Mrc/J 017569 STOCK Polr2atm1(cre/ERT2)Bbd E4f1tm1.1Llca/J 017585 STOCK Polr2atm1(cre/ERT2)Bbd/J 016963 STOCK Slc17a6tm2(cre)Lowl/J 016962 STOCK Slc32a1tm2(cre)Lowl/J 008783 STOCK Smn1tm3(SMN2/Smn1)Mrph Tg(SMN2*delta7)4299Ahmb Tg(SMN2)89Ahmb Tg(CAG-cre/Esr1*)5Amc/J 013044 STOCK Ssttm2.1(cre)Zjh/J 019508 STOCK Tcf21tm3.1(cre/Esr1*)Eno/J 012719 STOCK Tgfb3tm1(cre)Vk/J 012620 STOCK Trp53tm1Brd Brca1tm1Aash Tg(LGB-cre)74Acl/J 008813 STOCK Trpa1tm2Kykw Tg(CAG-cre/Esr1*)5Amc/J 010908 STOCK Viptm1(cre)Zjh/J 010911 STOCK Wt1tm1(EGFP/cre)Wtp/J 010912 STOCK Wt1tm2(cre/ERT2)Wtp/J 012691 STOCK Et(icre/ERT2)14374Rdav/J 012692 STOCK Et(icre/ERT2)14602Rdav/J 012693 STOCK Et(icre/ERT2)14624Rdav/J 007684 STOCK Tg(Atoh1-cre/Esr1*)14Fsh/J 004453 STOCK Tg(CAG-cre/Esr1*)5Amc/J 009615 STOCK Tg(Cartpt-cre)1Aibs/J 017336 STOCK Tg(Cd4-cre)1Cwi/BfluJ 005105 STOCK Tg(Chx10-EGFP/cre,-ALPP)2Clc/J 008861 STOCK Tg(Ela1-Cre/ERT2)1Stof/J 008852 STOCK Tg(En2-cre)22Alj/J 005938 STOCK Tg(Eno2-cre)39Jme/J 011062 STOCK Tg(Gdf9-cre)5092Coo/J 012841 STOCK Tg(Ggt1-cre)M3Egn/J 021207 STOCK Tg(Gnrh1-cre)1Dlc/J 017981 STOCK Tg(Hoxb6-cre)Mku/J 004692 STOCK Tg(Hoxb7-cre)13Amc/J 014600 STOCK Tg(I12b-cre/ERT2,-ALPP)37Fsh/J 008122 STOCK Tg(Ins2-cre/ERT)1Dam/J 004782 STOCK Tg(KRT14-cre)1Amc/J 005107 STOCK Tg(KRT14-cre/ERT)20Efu/J 008582 STOCK Tg(Kcnc2-Cre)K128Stl/LetJ 017836 STOCK Tg(LGB-cre)74Acl/J 003551 STOCK Tg(MMTV-cre)1Mam/J 003553 STOCK Tg(MMTV-cre)4Mam/J 002527 STOCK Tg(Mx1-cre)1Cgn/J 009074 STOCK Tg(Myh6-cre)1Jmk/J 005650 STOCK Tg(Myh6-cre/Esr1*)1Jmk/J 009102 STOCK Tg(Nefh-cre)12Kul/J 002858 STOCK Tg(Nes-cre)1Wme/J 002859 STOCK Tg(Nes-cre)2Wme/J 012859 STOCK Tg(Neurog1-cre)1Jejo/J 005667 STOCK Tg(Neurog3-cre)C1Able/J 008119 STOCK Tg(Neurog3-cre/Esr1*)1Dam/J 012462 STOCK Tg(Nr5a1-cre)7Lowl/J 014158 STOCK Tg(Pax4-cre)1Dam/J 006207 STOCK Tg(Pcp2-cre)1Amc/J 014099 STOCK Tg(Pmch-cre)1Lowl/J 005965 STOCK Tg(Pomc1-cre)16Lowl/J 012452 STOCK Tg(Rr5-GFP/cre)1Sapc/J 006395 STOCK Tg(Sim1-cre)1Lowl/J 009606 STOCK Tg(Six2-EGFP/cre)1Amc/J 018147 STOCK Tg(Slc17a8-icre)1Edw/SealJ 012586 STOCK Tg(Slc1a3-cre/ERT)1Nat/J 004783 STOCK Tg(Sox2-cre)1Amc/J 008208 STOCK Tg(Stra8-cre)1Reb/J 016236 STOCK Tg(TCF/Lef1-cre/ERT2)1Dje/J 004746 STOCK Tg(Tagln-cre)1Her/J 012708 STOCK Tg(Thy1-cre/ERT2,-EYFP)HGfng/PyngJ 016584 STOCK Tg(Tph2-icre/ERT2)6Gloss/J 003829 STOCK Tg(Wnt1-cre)11Rth Tg(Wnt1-GAL4)11Rth/J 008851 STOCK Tg(Wnt1-cre/ERT)1Alj/J 008199 STOCK Tg(dlx6a-cre)1Mekk/J 002471 STOCK Tg(hCMV-cre)140Sau/J 006224 STOCK Tg(tetO-cre)1Jaw/J View Strains carrying other alleles of cre (394 strains)
Introduction to Cre-lox technology
Visit the Parkinson's Disease Resource site for helpful information on Parkinson's and research resources.
View Related Disease (OMIM) Terms
Related Disease (OMIM) Terms provided by MGI
- Potential model based on gene homology relationships. Phenotypic similarity to the human disease has not been tested. Attention Deficit-Hyperactivity Disorder; ADHD (SLC6A3)
Major Affective Disorder 1; MAFD1 (SLC6A3)
Parkinsonism-Dystonia, Infantile; PKDYS (SLC6A3)
Tobacco Addiction, Susceptibility to (SLC6A3)
View Mammalian Phenotype Terms
Mammalian Phenotype Terms provided by MGI
assigned by genotype
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Slc6a3tm1.1(cre)Bkmn/Slc6a3tm1.1(cre)Bkmn
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
- normal phenotype
- no abnormal phenotype detected
- homozygous and heterozygous mice are normal and viable (MGI Ref ID J:114466)
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
cre relatedCell Biology Research
Channel and Transporter Defects
Neurobiology Research
Behavioral and Learning Defects
Channel and Transporter Defects
Neurotransmitter Receptor and Synaptic Vesicle Defects
Research Tools
Cre-lox System
Cre Recombinase Expression
Cre Recombinase Expression: Germline/Embryonic Expression
Genetics Research
Mutagenesis and Transgenesis
Mutagenesis and Transgenesis: Cre-lox System
Slc6a3tm1.1(cre)Bkmn relatedResearch Tools
Cre-lox System
Genetics Research
Mutagenesis and Transgenesis
Mutagenesis and Transgenesis: Cre-lox System
Neurobiology Research
Parkinson's Disease
strains expressing cre
| Allele Symbol | Slc6a3tm1.1(cre)Bkmn | ||
|---|---|---|---|
| Allele Name | targeted mutation 1.1, Cristina M Backman | ||
| Allele Type | Targeted (knock-in) | ||
| Common Name(s) | DatIREScre; | ||
| Mutation Made By | Andreas Tomac, National Institute on Drug Abuse (NIH) | ||
| ES Cell Line Name | Other (see notes) | ||
| Site of Expression | Cre recombinase activity is observed as early as embryonic day 15, and co-localizes with endogenous gene expression in adult dopaminergic cell groups (substantia nigra (SN) and ventral tegmental area (VTA), as well as in the retrorubral field). Lesser Cre recombinase activity occurs in adult olfactory bulb glomeruli, mimicking the known lower Slc6a3 (or DAT) expression in this tissue. | ||
| Expressed Gene | cre, cre recombinase, bacteriophage P1 | ||
| Cre recombinase is an enzyme derived from the bacteriophage P1 that specifically recognizes loxP sites. Cre has been shown to effectively mediate the excision of DNA located between loxP sites. After the excision event, the DNA ends recombine leaving a single loxP site in place of the intervening sequence. | |||
| Driver Note | Slc6a3 | ||
| General Note | The targeting vector was electroporated into both R1 and C57BL/6 ES cells. | ||
| Molecular Note | An FRT-flanked neo was removed from the locus, leaving cre recombinase cDNA in the 3' UTR to allow bicistronic mRNA expression. [MGI Ref ID J:114466] | ||
| Gene Symbol and Name | Slc6a3, solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | ||
| Chromosome | 13 | ||
| Gene Common Name(s) | DAT; DAT1; Dat1; PKDYS; dopamine transporter 1; | ||
Genotyping Protocols
Slc6a3tm1.1(cre)Bkmn, Melt Curve Analysis
Slc6a3tm1.1(cre)Bkmn, Standard PCR
Helpful Links
Genotyping resources and troubleshooting
Backman CM; Malik N; Zhang Y; Shan L; Grinberg A; Hoffer BJ; Westphal H; Tomac AC. 2006. Characterization of a mouse strain expressing Cre recombinase from the 3' untranslated region of the dopamine transporter locus. Genesis 44(8):383-90. [PubMed: 16865686] [MGI Ref ID J:114466]
Slc6a3tm1.1(cre)Bkmn relatedBello EP; Mateo Y; Gelman DM; Noain D; Shin JH; Low MJ; Alvarez VA; Lovinger DM; Rubinstein M. 2011. Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors. Nat Neurosci 14(8):1033-8. [PubMed: 21743470] [MGI Ref ID J:176167]
Cohen JY; Haesler S; Vong L; Lowell BB; Uchida N. 2012. Neuron-type-specific signals for reward and punishment in the ventral tegmental area. Nature 482(7383):85-8. [PubMed: 22258508] [MGI Ref ID J:181307]
Di Salvio M; Di Giovannantonio LG; Acampora D; Prosperi R; Omodei D; Prakash N; Wurst W; Simeone A. 2010. Otx2 controls neuron subtype identity in ventral tegmental area and antagonizes vulnerability to MPTP. Nat Neurosci 13(12):1481-8. [PubMed: 21057506] [MGI Ref ID J:166896]
Diaz-Ruiz O; Zapata A; Shan L; Zhang Y; Tomac AC; Malik N; de la Cruz F; Backman CM. 2009. Selective deletion of PTEN in dopamine neurons leads to trophic effects and adaptation of striatal medium spiny projecting neurons. PLoS One 4(9):e7027. [PubMed: 19750226] [MGI Ref ID J:153622]
Genetic Resource Sciences at The Jackson Laboratory. 2013. Expression/Specificity Patterns of Cre Alleles, 2013 MGI Direct Data Submission :. [MGI Ref ID J:193672]
Pham AH; Meng S; Chu QN; Chan DC. 2012. Loss of Mfn2 results in progressive, retrograde degeneration of dopaminergic neurons in the nigrostriatal circuit. Hum Mol Genet 21(22):4817-26. [PubMed: 22859504] [MGI Ref ID J:188347]
Ziegler CG; Peng M; Falk MJ; Polyak E; Tsika E; Ischiropoulos H; Bakalar D; Blendy JA; Gasser DL. 2012. Parkinson's disease-like neuromuscular defects occur in prenyl diphosphate synthase subunit 2 (Pdss2) mutant mice. Mitochondrion 12(2):248-57. [PubMed: 21983691] [MGI Ref ID J:192142]
Animal Health Reports
Room Number AX11
Colony Maintenance
Breeding & Husbandry When maintaining a live colony, heterozygous mice are bred to wildtype siblings or to inbred C57BL/6J (Stock No. 000664). Homozygous mice have approximately half of the endogenous gene expression associated with altered neuropeptide levels in the brain, while heterozygotes have a moderate, non-significant reduction in endogenous gene expression with no reported neuropeptide abnormalities. Mating System +/+ sibling x Heterozygote (Female x Male) 16-DEC-08 Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
Price per mouse (US dollars $) Gender Genotypes Provided Individual Mouse $232.00 Female or Male Heterozygous for Slc6a3tm1.1(cre)Bkmn
Price per Pair (US dollars $) Pair Genotype $296.00 Heterozygous for Slc6a3tm1.1(cre)Bkmn x Wild-type for Slc6a3tm1.1(cre)Bkmn $296.00 Wild-type for Slc6a3tm1.1(cre)Bkmn x Heterozygous for Slc6a3tm1.1(cre)Bkmn Standard Supply
Repository-Live. Repository-Live represents an exclusive set of over 1500 unique mouse models maintained at The Jackson Laboratory to support a vast array of research areas. The breeding colonies for Repository Strains provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. Repository-live orders are treated as custom orders. Within 2 business days, we respond to each availability inquiry or order with various delivery options. Repository Strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping.
| Pricing for International shipping destinations |
|
Price per mouse (US dollars $) Gender Genotypes Provided Individual Mouse $301.60 Female or Male Heterozygous for Slc6a3tm1.1(cre)Bkmn
Price per Pair (US dollars $) Pair Genotype $384.80 Heterozygous for Slc6a3tm1.1(cre)Bkmn x Wild-type for Slc6a3tm1.1(cre)Bkmn $384.80 Wild-type for Slc6a3tm1.1(cre)Bkmn x Heterozygous for Slc6a3tm1.1(cre)Bkmn Standard Supply
Repository-Live. Repository-Live represents an exclusive set of over 1500 unique mouse models maintained at The Jackson Laboratory to support a vast array of research areas. The breeding colonies for Repository Strains provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. Repository-live orders are treated as custom orders. Within 2 business days, we respond to each availability inquiry or order with various delivery options. Repository Strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping.
|
|
Repository-Live. Repository-Live represents an exclusive set of over 1500 unique mouse models maintained at The Jackson Laboratory to support a vast array of research areas. The breeding colonies for Repository Strains provide mice for both large and small orders and fluctuate in size depending on current demand for each strain. Repository-live orders are treated as custom orders. Within 2 business days, we respond to each availability inquiry or order with various delivery options. Repository Strains typically are delivered at 4 to 8 weeks of age and will not exceed 12 weeks of age on the day of shipping.
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
| Control Pricing Information for Genetically Engineered Mutant Strains. | ||
For Licensing and Use Restrictions view the link(s) below:
- Strain(s) not available to companies or for-profit entities.
- Strain(s) not available to companies or for-profit entities.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.